What is CONCOR-DONOR?
CONCOR-DONOR is a longitudinal cohort study of adults who have recovered from COVID-19 and have volunteered to donate convalescent plasma.
The outbreak caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has risen to the level of a global pandemic, affecting more than 4 million individuals worldwide in 187 countries, with a case fatality rate of 6.9% (as of May 11, 2020).
There are currently no proven treatments for coronavirus disease (COVID-19); however, convalescent plasma has emerged as a potential therapeutic to prevent clinical deterioration. The unknown role for convalescent plasma in treating COVID-19 necessitates further study.
As trials are underway to determine the efficacy of using convalescent plasma to treat COVID-19, we will use this unique opportunity to conduct a national longitudinal cohort study of ~2400 persons >17 years of age recovered from COVID-19 who volunteer to donate their convalescent plasma.
If you are interested in participating in CONCOR-DONOR, please fill out the interest form by clicking the link below